MedPath

Evaluation of the effect of Brazilian Propolis on mouth Inflammation (Mucositis) in patients undergoing treatment for Head and Neck Cancer

Phase 1
Conditions
Two groups of intervention participants: (1) individuals without any underlying pathology or disease for toxicity assessment (2) individuals being treated for head and neck cancer by chemotherapy and radiotherapy, for assessment of anti-inflammatory profile on oral mucositis (stomatitis).
Registration Number
RBR-76vd5wf
Lead Sponsor
niversidade de Franca
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Phase 1: Volunteers over 18 years old; in full health;
Phase 2: Volunteers over 18 years old; in head and neck cancer treatment; in radiotherapy and chemotherapy treatment with cisplatin; with the presence of mucositis.

Exclusion Criteria

Phase 1: individuals who have any type of disease, linked or not to cancer;
Phase 2: individuals in oncology, with chemotherapy other than cisplatin.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anti-inflammatory action of 5% red propolis gel and reduction in the mucositis index with a decrease in the degree of mucositis = 0 according to the WHO classification.
Secondary Outcome Measures
NameTimeMethod
Improvement in the quality of life of individuals with mucositis, aiding in the ingestion of solid foods, increasing their nutritional supply; absence of opportunistic candidiasis
© Copyright 2025. All Rights Reserved by MedPath